FeesSafety
Pluang+

Target Hospitality reports 30% revenue growth and $1.7B in new contracts, expanding workforce housing capacity.

Company Fundamentals
09 Nov 2026, 13:45 WIB
PRNewsWire
View Source
Bullish
Target Hospitality reports 30% revenue growth and $1.7B in new contracts, expanding workforce housing capacity.

Target Hospitality announced a 30% year-over-year revenue increase to $129.1 million for Q3 2026, driven by growth in its Workforce Hospitality Solutions segment. The company secured over $1.7 billion in multi-year contracts since January 2026, adding more than 10,000 beds and scaling utilized beds to over 6,200. Despite a net loss of $9.2 million, adjusted EBITDA rose 59% to $34.2 million with margin expansion, reflecting operational efficiencies and higher-margin services. Target expects continued growth into 2027, supported by a strong contract pipeline and expanding service offerings in critical infrastructure projects.

Target Hospitality's Q3 2026 results provide context for readers. For those following the Industrials sector, here is Pluang's market snapshot as of Nov 09, 2026 18:11 WIB: out of 135 priced US stocks, 94 rose and 15 fell. Among notable movers, Axon Enterprise Inc (AXON) traded at USD 322.00 with a 1-day change of +2.88%, CMB.TECH NV (CMBT) at USD 17.09 with +2.77%, and Plug Power Inc (PLUG) at USD 1.49 with +2.76%. Typical hold times on Pluang range from 17 to 43 days for these assets.

More News

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft to retire UWP Map Control by Nov 2026; OnTerra offers ready replacement using Azure Maps.

Microsoft will retire the backend services for its UWP Map Control and Windows Maps APIs on November 30, 2026, ending map functionality in many Windows desktop and tablet applications. OnTerra Systems, a Microsoft partner, has developed an off-the-sh...

Market News
Neutral
1 hour ago
New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

New combo therapy shows promise in tough metastatic breast cancer cases with high response rates

Marengo Therapeutics presented interim Phase 2 results from the STARt-002 trial combining invikafusp alfa, a selective T-cell agonist, with sacituzumab govitecan in metastatic triple-negative and HR-positive/HER2-negative breast cancer. The trial sho...

Company Fundamentals
Bullish
2 hours ago
Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Deadlines set for lead plaintiff appointments in class action lawsuits against Ensign, Netcapital, and Webull.

Holzer & Holzer, LLC announced deadlines for investors to seek lead plaintiff status in shareholder class action lawsuits against The Ensign Group, Netcapital Inc., and Webull Corporation. These lawsuits allege misleading statements and failure to di...

Bearish
2 hours ago
Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave launches Attune Facilities, an AI-driven tool for managing complex multi-site operations efficiently.

Octave Intelligence plc has introduced Octave Attune Facilities, a cloud-based software solution designed to help organizations manage multiple sites with AI-powered tools. This platform integrates building, space, maintenance, and operational data t...

Market News
Bullish
2 hours ago
ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. price target raised to $259 after strong Q3 with 44% revenue growth and 20% earnings rise.

ITT Inc. reported a strong third quarter with revenue up 44% to over $1.40 billion and adjusted earnings rising 20% to $2.26 per share, driven by the SPX FLOW acquisition and 8% organic growth. Orders surged 58%, supported by aerospace, defense, and ...

Analyst Insights
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App